Rajiv Shukla
DirectoratHumacyte· In proxies 2023–2024
Rajiv Shukla sits on 1 public board.
Experience
- HumacytePublic company · 3 yr
- Director2023 – Present · 3 yrStock in role -77%
- InflammX TherapeuticsPublic company
- Director? – PresentNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?